University Hospitals Birmingham NHS Foundation Trust

Reports

Status Drug name NICE TAs Comments
Status: Red Finasteride 1mg tablets

Hyperandrogenism in women

Status: Green Finasteride 5mg tablets

Men

Status: Green Finerenone (Kerendia®)

Prescribing to be in line with the prescribing support document

Status: Amber Flash glucose monitoring system  (FreeStyle Libre 2®, FreeStyle Libre®)
Status: Amber Flecainide injection

Hospital only

Status: Amber Flexitol® 25% urea heak balm

Specialist recommendation

Status: Green Flucitasone and salmeterol

APC listing of current formulary brands

Status: Green Flucitasone and salmeterol (Seretide®)

For existing patients, for paediatric use only (i.e. up to 18 years of age) - APC listing of current formulary brands

Status: Green Flucitasone furoate (Avamys)

Approved for use in children and adults. Previous APC decision reviewed in December 2015.

Status: Amber Flucitasone inhaler (Flixotide) evohaler 125 / Fluticasone accuhaler 250

For paediatric use only

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.

Building healthier lives
Back to top